Google
Interventional Cardiology 2015: 30th Annual International SymposiumTake Evaluation

Interventional Cardiology 2015: 30th Annual International Symposium
Mar 1-6, 2015

The Houston Aortic Symposium 2015Take Evaluation

The Houston Aortic Symposium 2015
Mar 5-7, 2015

Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium

register

Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium
Oct 1-2, 2015

Controversies and Advances in the Treatment of Cardiovascular Disease: The Fifteenth in the Series

register
submit abstract

Controversies and Advances in the Treatment of Cardiovascular Disease: The Fifteenth in the Series
Nov 19-20, 2015

The Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, the Ninth in the Series

register
submit abstract

The Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, the Ninth in the Series
Mar 3-5, 2016

Interventional Cardiology 2016: 31st Annual International Symposium

register
submit abstract

Interventional Cardiology 2016: 31st Annual International Symposium
Mar 6-11, 2016

International Academy of Cardiology, Annual Scientific Sessions 2015: 20th World Congress on Heart Disease

International Academy of Cardiology, Annual Scientific Sessions 2015: 20th World Congress on Heart Disease
Jul 25-27, 2015

Interventional Cardiology 2008 DVD Teaching Program

shop

Interventional Cardiology 2008 DVD Teaching Program

Discuss prevention of the escalation of diabetes in the United States at
CDM 2015 in Phoenix!

Controversies & Advances DVD Teaching Program

shop

Controversies & Advances DVD Teaching Program

Frontiers in Cardiovascular Diseases Book

shop
Hazim J. Safi, MD & David D. McPherson, MD

Frontiers in Cardiovascular Diseases Book

Share your thoughts in our Learn From The Leaders Forum!

Discussion on PCSK9 Inhibitors

A 65 year old asymptomatic woman sees you for therapy. She has a positive family history of early CV mortality. Her cholesterol is over 400 with intolerance to statins. She carries a diagnosis of homozygous familial hypercholesterolemia (HoFH). What is the role of the new PCSK9 inhibitors in treating patients like the one described above?

Dr. Heuser is interested to hear what your approach would be with this patient. Please comment below with your thoughts.

We hope to see you at the upcoming Cardiovascular Disease Management symposium, taking place October 1-2, 2015. For the detailed program, registration, CME, and hotel information, please visit: http://promedicacme.com/meeting/Cardiovascular-Disease-Management-A-Case-Based-110.html.

more»

LATEST SLIDESHOW

RECENT CONTRIBUTORS